findmyKOL
Clinical trialNCT01207726TerminatedPhase 2Interventional

Azacitidine and Entinostat in Treating Patients With Stage I Non-Small Cell Lung Cancer That Has Been Removed By Surgery

SponsorNational Cancer Institute (NCI)Enrollment13Stage IA Non-Small Cell Lung CarcinomaStage IB Non-Small Cell Lung Carcinoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Usc / Norris Comprehensive Cancer Center

    Los Angeles, California, United States

  • Moffitt Cancer Center

    Tampa, Florida, United States

  • Anne Arundel Medical Center

    Annapolis, Maryland, United States

  • Greater Baltimore Medical Center

    Baltimore, Maryland, United States

  • Johns Hopkins Bayview Medical Center

    Baltimore, Maryland, United States

  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital

    Baltimore, Maryland, United States

  • University of Pittsburgh Cancer Institute

    Pittsburgh, Pennsylvania, United States

  • Vanderbilt-Ingram Cancer Center

    Nashville, Tennessee, United States

  • University of Texas Southwestern Medical Center

    Dallas, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Sept 2010
Primary completion
31 May 2013
Completion
31 May 2013
Last update posted
5 Feb 2019
Registered enrollment
13
Registry id
NCT01207726

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.